These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 32477831)
1. Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma. Zhang XY; Rajagopalan D; Chung TH; Hooi L; Toh TB; Tian JS; Rashid MBMA; Sahib NRBM; Gu M; Lim JJ; Wang W; Chng WJ; Jha S; Chow EK Exp Hematol Oncol; 2020; 9():8. PubMed ID: 32477831 [TBL] [Abstract][Full Text] [Related]
2. G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor-mediated cell death. De Smedt E; Devin J; Muylaert C; Robert N; Requirand G; Vlummens P; Vincent L; Cartron G; Maes K; Moreaux J; De Bruyne E Blood Adv; 2021 May; 5(9):2325-2338. PubMed ID: 33938943 [TBL] [Abstract][Full Text] [Related]
3. The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. Chen X; El Gazzar M; Yoza BK; McCall CE J Biol Chem; 2009 Oct; 284(41):27857-27865. PubMed ID: 19690169 [TBL] [Abstract][Full Text] [Related]
4. Abnormal overexpression of G9a in melanoma cells promotes cancer progression via upregulation of the Notch1 signaling pathway. Dang NN; Jiao J; Meng X; An Y; Han C; Huang S Aging (Albany NY); 2020 Feb; 12(3):2393-2407. PubMed ID: 32015216 [TBL] [Abstract][Full Text] [Related]
5. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer. Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834 [TBL] [Abstract][Full Text] [Related]
6. Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis. Ishiguro K; Kitajima H; Niinuma T; Maruyama R; Nishiyama N; Ohtani H; Sudo G; Toyota M; Sasaki H; Yamamoto E; Kai M; Nakase H; Suzuki H Cell Death Discov; 2021 Jan; 7(1):7. PubMed ID: 33436557 [TBL] [Abstract][Full Text] [Related]
7. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth. Vallabhapurapu SD; Noothi SK; Pullum DA; Lawrie CH; Pallapati R; Potluri V; Kuntzen C; Khan S; Plas DR; Orlowski RZ; Chesi M; Kuehl WM; Bergsagel PL; Karin M; Vallabhapurapu S Nat Commun; 2015 Oct; 6():8428. PubMed ID: 26455434 [TBL] [Abstract][Full Text] [Related]
9. Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway. Roy P; Mukherjee T; Chatterjee B; Vijayaragavan B; Banoth B; Basak S Oncogene; 2017 Mar; 36(10):1417-1429. PubMed ID: 27641334 [TBL] [Abstract][Full Text] [Related]
10. G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway. Sun T; Zhang K; Pangeni RP; Wu J; Li W; Du Y; Guo Y; Chaurasiya S; Arvanitis L; Raz DJ Mol Cancer Res; 2021 Mar; 19(3):429-440. PubMed ID: 33298547 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma. Li KC; Hua KT; Lin YS; Su CY; Ko JY; Hsiao M; Kuo ML; Tan CT Mol Cancer; 2014 Jul; 13():172. PubMed ID: 25027955 [TBL] [Abstract][Full Text] [Related]
12. RNA-seq and miRNA-seq data from pharmacological inhibition of the G9a/GLP histone methyltransferase complex with UNC0642 in SAMP8 mice. Pawar S; Bellver-Sanchis A; Griñán-Ferré C Data Brief; 2021 Jun; 36():107114. PubMed ID: 34307805 [TBL] [Abstract][Full Text] [Related]
13. The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway. Ma W; Han C; Zhang J; Song K; Chen W; Kwon H; Wu T Hepatology; 2020 Oct; 72(4):1283-1297. PubMed ID: 31990985 [TBL] [Abstract][Full Text] [Related]
14. ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myeloma. Jiang J; Sun Y; Xu J; Xu T; Xu Z; Liu P Cancer Med; 2020 Oct; 9(19):7244-7252. PubMed ID: 32780537 [TBL] [Abstract][Full Text] [Related]
15. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis. Casciello F; Al-Ejeh F; Kelly G; Brennan DJ; Ngiow SF; Young A; Stoll T; Windloch K; Hill MM; Smyth MJ; Gannon F; Lee JS Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7077-7082. PubMed ID: 28630300 [TBL] [Abstract][Full Text] [Related]
16. Frequent engagement of RelB activation is critical for cell survival in multiple myeloma. Cormier F; Monjanel H; Fabre C; Billot K; Sapharikas E; Chereau F; Bordereaux D; Molina TJ; Avet-Loiseau H; Baud V PLoS One; 2013; 8(3):e59127. PubMed ID: 23555623 [TBL] [Abstract][Full Text] [Related]
17. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma. Lin X; Huang Y; Zou Y; Chen X; Ma X Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761 [TBL] [Abstract][Full Text] [Related]
18. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer. Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140 [TBL] [Abstract][Full Text] [Related]
19. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer. Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169 [TBL] [Abstract][Full Text] [Related]
20. GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death. Alves-Silva JC; de Carvalho JL; Rabello DA; Serejo TRT; Rego EM; Neves FAR; Lucena-Araujo AR; Pittella-Silva F; Saldanha-Araujo F Invest New Drugs; 2018 Oct; 36(5):955-960. PubMed ID: 29855824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]